Regeneron Posts Positive Initial Data On Its Covid-19 Treatment

Regeneron Posts Positive Initial Data On Its Covid-19 Treatment

Regeneron Pharmaceuticals posted positive data from its Covid-19 treatment trials; an announcement that came after the close of Tuesday's session but could spark REGN stock.